A retrospective comparison of concurrent bolus 5-fluorouracil or raltitrexed in preoperative chemoradiation for locally advanced rectal cancer
BACKGROUND: 5-fluorouracil (FU) is commonly used in preoperative chemoradiation in locally advanced rectal cancer, but not all patients cooperate in taking the 5-day continuous infusion regimen. Raltitrexed (RA), a thymidylate synthase inhibitor, is one of the agents used in place of FU in such case...
Main Authors: | Adnan Yoney, Bulent Askaroglu, Tayfun Hancilar, Levent Isikli, Mustafa Unsal |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2008-01-01
|
Series: | Hematology/Oncology and Stem Cell Therapy |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1658387608500574 |
Similar Items
-
Preoperative chemoradiation in locally advanced rectal cancer: A comparison of bolus 5-fluorouracil/leucovorin and capecitabine
by: Adnan Yoney, et al.
Published: (2014-01-01) -
Raltitrexed versus 5‐fluorouracil with cisplatin and concurrent radiotherapy for locally advanced nasopharyngeal carcinoma: An open labeled, randomized, controlled, and multicenter clinical trial
by: Pengwei Yan, et al.
Published: (2020-09-01) -
PREOPERATIVE CHEMORADIATION FOR LOCALLY ADVANCED LOW LYING RECTAL CANCER: PRELIMINARY RESULTS
by: A. Abasahl R. Omranipour
Published: (2006-05-01) -
PREOPERATIVE CHEMORADIATION FOR LOCALLY ADVANCED LOW LYING RECTAL CANCER: PRELIMINARY RESULTS
by: A. Abasahl R. Omranipour
Published: (2006-02-01) -
Treatment of resectable distal rectal cancer with preoperative chemoradiation and sphincter saving surgery
by: Omrani Pour R, et al.
Published: (2000-06-01)